Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02294981 · ClinicalTrials.gov registry record · NA
Excimer Laser Phototherapy Outcomes in the Treatment of Psoriasis
A NA study, sponsored by University of California, San Francisco.
- Terminated
- Registry status
- NA
- Development phase
- 4
- Enrollment target
NCT02294981: Clinical Trial NA study, sponsored by University of California, San Francisco.
NCT02294981 is a NA study that was terminated before completion, run by University of California, San Francisco. The registered enrollment target is 4 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02294981, a NA study, was terminated before completion, sponsored by University of California, San Francisco.
- TERMINATED
- Registry status
- NA
- Development phase
- 4 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the best dosing strategy when using Excimer Laser to treat plaque-type psoriasis. In this study, half of the body's psoriasis will be treated with a new dosing strategy, and the other half will be treated with the conventional method. We hope to show that the new dosing strategy will result in faster improvement of psoriasis.
Primary Outcome
The Modified Psoriasis Area Severity Index is a scale that grades psoriasis based on thickness, redness, scaling, and area involvement.
Interventions
- DEVICE Excimer laser phototherapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4 participants |
| Start Date | 2016-01 |
| Est. Completion | 2017-09 |
| Phase | NA |
Why NCT02294981 stopped before completion
NCT02294981 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 4 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 1 intervention - of which Excimer laser phototherapy is the first listed.
NCT02294981 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02294981 about?
NCT02294981 is a clinical study titled "Excimer Laser Phototherapy Outcomes in the Treatment of Psoriasis". The purpose of this study is to determine the best dosing strategy when using Excimer Laser to treat plaque-type psoriasis. In this study, half of the body's psoriasis will be treated with a new dosing strategy, and the other half will be treated with the conventional method. We hope to show that th...
What is the current status of trial NCT02294981?
This trial is currently terminated. It is a NA study. The enrollment target is 4 participants. The study started on 2016-01. Estimated completion is 2017-09.
What interventions are being tested in trial NCT02294981?
The interventions under investigation include: Excimer laser phototherapy (DEVICE).
Who is sponsoring clinical trial NCT02294981?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02294981's enrollment target sits among peer trials
4 1996th of 2000 higher than 5 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia